William Blair Comments on Medtronic's Q3 Earnings (NYSE:MDT)

Medtronic plc (NYSE:MDT - Free Report) - Analysts at William Blair issued their Q3 2027 earnings per share estimates for Medtronic in a research note issued on Wednesday, May 21st. William Blair analyst M. Andrew forecasts that the medical technology company will post earnings of $1.46 per share for the quarter. The consensus estimate for Medtronic's current full-year earnings is $5.46 per share.

Several other equities research analysts also recently weighed in on MDT. Needham & Company LLC reaffirmed a "hold" rating on shares of Medtronic in a research report on Monday, May 19th. Robert W. Baird decreased their target price on Medtronic from $94.00 to $92.00 and set a "neutral" rating for the company in a research report on Thursday, May 22nd. UBS Group upped their target price on Medtronic from $85.00 to $95.00 and gave the stock a "neutral" rating in a research report on Wednesday, February 19th. Royal Bank of Canada decreased their target price on Medtronic from $105.00 to $101.00 and set an "outperform" rating for the company in a research report on Thursday, May 22nd. Finally, Truist Financial decreased their target price on Medtronic from $93.00 to $90.00 and set a "hold" rating for the company in a research report on Friday, April 11th. One research analyst has rated the stock with a sell rating, nine have given a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $96.07.

Medtronic Trading Up 0.9%

MDT stock traded up $0.77 during trading on Monday, reaching $82.01. 3,825,914 shares of the stock traded hands, compared to its average volume of 6,806,680. The business's 50 day moving average price is $84.46 and its 200-day moving average price is $86.28. Medtronic has a 52-week low of $75.96 and a 52-week high of $96.25. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.90 and a quick ratio of 1.39. The firm has a market capitalization of $105.18 billion, a PE ratio of 24.93, a P/E/G ratio of 2.22 and a beta of 0.81.

Medtronic (NYSE:MDT - Get Free Report) last posted its quarterly earnings results on Wednesday, May 21st. The medical technology company reported $1.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.58 by $0.04. Medtronic had a return on equity of 14.07% and a net margin of 12.83%. The firm had revenue of $8.93 billion during the quarter, compared to the consensus estimate of $8.81 billion. During the same quarter in the previous year, the business earned $1.46 earnings per share. The firm's quarterly revenue was up 3.9% compared to the same quarter last year.

Hedge Funds Weigh In On Medtronic

Institutional investors have recently bought and sold shares of the stock. Mainstream Capital Management LLC acquired a new stake in Medtronic during the fourth quarter worth about $26,000. Burkett Financial Services LLC boosted its holdings in Medtronic by 185.0% during the first quarter. Burkett Financial Services LLC now owns 285 shares of the medical technology company's stock valued at $26,000 after purchasing an additional 185 shares in the last quarter. 1248 Management LLC acquired a new stake in Medtronic during the first quarter valued at approximately $26,000. Stephens Consulting LLC boosted its holdings in Medtronic by 145.7% during the fourth quarter. Stephens Consulting LLC now owns 344 shares of the medical technology company's stock valued at $27,000 after purchasing an additional 204 shares in the last quarter. Finally, Rakuten Securities Inc. boosted its holdings in Medtronic by 753.8% during the fourth quarter. Rakuten Securities Inc. now owns 333 shares of the medical technology company's stock valued at $27,000 after purchasing an additional 294 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Medtronic Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.71 per share. This is a positive change from Medtronic's previous quarterly dividend of $0.70. This represents a $2.84 annualized dividend and a yield of 3.46%. The ex-dividend date is Friday, June 27th. Medtronic's dividend payout ratio (DPR) is 78.45%.

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.